UT San Antonio
UT Health San Antonio
Category ID
295

UT Health Science Center San Antonio seeks volunteers to join VIVA-MIND study of an oral drug for Alzheimer’s

Volunteers 50 to 89 with a diagnosis of mild cognitive impairment or probable mild AD may ask about eligibility to participate in VIVA-MIND, a study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems.

Share This Story

UT Health Science Center San Antonio recognized as Parkinson’s Foundation Comprehensive Care Center

The University of Texas Health Science Center at San Antonio has been designated a Parkinson’s Foundation Comprehensive Care Center, the first of its kind in the state of Texas.

Share This Story

UT Health San Antonio: Using AI to diagnose brain disease in seconds

Novel AI algorithm precisely counts lesions that signal risk of stroke.

Share This Story

Could enhancing the body’s own marijuana-like chemical treat Alzheimer’s?

  Can the body’s naturally occurring “pot” be boosted in the brain to treat Alzheimer’s disease? A researcher at The University of Texas Health Science Center at San Antonio is studying that intriguing question with $4.4 million in newly awarded funding from the National Institutes of Health. Delta9-tetrahydrocannabinol (THC), derived from marijuana or cannabis plants, […]

Share This Story

300 attend ‘Think Science: Dementia in South Texas’

Clinical trials, brain and biobank donation and risk factors among topics discussed “Think Science: Dementia in South Texas,” a live event moderated by Nathan Cone of Texas Public Radio, drew 300 people to the Joe R. and Teresa Lozano Long Campus June 7 for an intriguing and inspiring discussion of a topic important to so […]

Share This Story

Infection Control Today: How Can Physical Medicine and Rehabilitation Help COVID Long-Haulers?

Monica Verduzco-Gutierrez, MD, professor and chair, Rehabilitation Medicine, was interviewed for this story.   Watch Now

Share This Story

HCPLive: Advanced Brain Aging Observed in Older Type 1 Diabetes Patients Compared to Those Without

Mohamad Habes, PhD, Glenn Biggs Institute/Radiology, was quoted in this article.   Read More

Share This Story

MedPage Today: Study Suggests Increase in Brain Aging in Those With Type 1 Diabetes

Mohamad Habes, PhD, Radiology, and his colleagues, were quoted in this article.   Read More

Share This Story

Becker’s Hospital Review: 7 cancer study updates to know

Andrew Brenner, MD, Neurosurgery,  and William Kelly, MD, Hematology & Oncology, both of the UT Health San Antonio Mays Cancer Center, were mentioned in this story via the word ‘conducted,’ which links to the university’s press release about the Mays Cancer Center conducting the only clinical trial in America of a specific drug combination for […]

Share This Story

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at The University of Texas Health Science Center at San Antonio about the study drug donanemab

  Alicia S. Parker, MD, of The University of Texas Health Science Center at San Antonio, is assistant professor of cognitive and behavioral neurology and clinic director for the health science center’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases. The Biggs Institute, in partnership with The University of Texas Rio Grande Valley, is Texas’ […]

Share This Story

Subscribe to Brain Health